Abstract 822: Target-specific nanoparticle-based strategy for improved therapeutic efficacy to treat pancreatic cancer

作者
Juan Luis Vivero-Escoto,Mubin Tarannum,Pinku Mukherjee
出处
期刊:Cancer Research [American Association for Cancer Research]
卷期号:83 (7_Supplement): 822-822 被引量:3
标识
DOI:10.1158/1538-7445.am2023-822
摘要

Abstract Pancreatic ductal adenocarcinoma (PDAC) accounts for over 90% of the pancreatic cancer cases and is the fourth-leading cause of cancer-related mortality. Unfortunately, despite the tremendous scientific efforts, it is shocking to note that PDAC has the worst prognosis with 5-year survival rate of 10% which has not significantly improved from the past 40 years. The high mortality and awful prognosis of PDAC can be attributed to multifactorial reasons like its intrinsic and acquired resistant behavior, early micrometastatic dissemination, desmoplastic effect and heterogeneities in tumors, rendering the current treatments rather ineffective. Developing reliable methods for the effective treatment of PDAC will have a major impact on the clinical outcome for this deadly disease. Nanoparticle-based drug delivery using mesoporous silica nanoparticles (MSNs) can be a potential alternative for the treatment of PDAC owing to their outstanding properties such as high surface area, tunable pore diameters, external and internal surface, which make this platform suitable for high drug loading and functionalization. We have designed, synthesized and characterized a target-specific, stimuli-responsive MSN platform for the controlled delivery of cisplatin (cisPt) and gemcitabine (Gem) (TAB004-Gem-cisPt-MSNs) with an optimal drug ratio. Our results demonstrate that this delivery system effectively targets tumor associated MUC1 (tMUC1), increases therapeutic efficiency with reduced toxicity in both a syngeneic and a spontaneous mouse model that overexpressed tMUC1. Moreover, the same MSN platform has been used in a sequential treatment where MSNs containing a Sonic Hedgehog (SHh) inhibitor, cyclopamine (CyP), and the Gem-cisPt-MSNs as the main delivery system led to reduction in the tumor stroma along with an improvement in the treatment of PDAC. Taken together, our findings support the potential of drug delivery using MSN nanoparticles for stroma modulation and to prevent pancreatic cancer progression. Citation Format: Juan Luis Vivero-Escoto, Mubin Tarannum, Pinku Mukherjee. Target-specific nanoparticle-based strategy for improved therapeutic efficacy to treat pancreatic cancer [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2023; Part 1 (Regular and Invited Abstracts); 2023 Apr 14-19; Orlando, FL. Philadelphia (PA): AACR; Cancer Res 2023;83(7_Suppl):Abstract nr 822.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
master发布了新的文献求助30
1秒前
ZZXX完成签到 ,获得积分10
2秒前
3秒前
zzz发布了新的文献求助10
4秒前
醉熏的小小完成签到 ,获得积分10
5秒前
SAKURA的应助被7895764采纳,获得10
5秒前
秋风的应助被张伟采纳,获得20
9秒前
xiedi给liu的求助进行了留言
10秒前
soledadyu关注了科研通微信公众号
10秒前
shuyiWang发布了新的文献求助10
10秒前
正直小蚂蚁完成签到,获得积分10
10秒前
慕青的应助被易宋采纳,获得30
11秒前
zheng-homes完成签到,获得积分10
11秒前
罗大海完成签到,获得积分10
11秒前
zont1x发布了新的文献求助10
12秒前
master完成签到,获得积分10
12秒前
12秒前
wkkk完成签到,获得积分10
12秒前
无辜的亦瑶完成签到 ,获得积分10
14秒前
Sakura完成签到 ,获得积分10
15秒前
Moonds完成签到,获得积分10
15秒前
15秒前
深情安青的应助被叮咚咚采纳,获得10
16秒前
13333完成签到,获得积分10
16秒前
17秒前
17秒前
无极微光的应助被cr7采纳,获得20
18秒前
20秒前
graves完成签到,获得积分10
20秒前
英姑的应助被砥砺前行采纳,获得10
20秒前
soledadyu发布了新的文献求助10
22秒前
尊敬鸿发布了新的文献求助10
23秒前
Joanne_yu完成签到 ,获得积分10
24秒前
24秒前
叁月二完成签到 ,获得积分10
25秒前
顺利鸡完成签到,获得积分10
26秒前
27秒前
27秒前
27秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Boundaries and Bodhisattvas 500
高分子基功能界面水蒸发材料与应用研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8181823
求助须知:如何正确求助?哪些是违规求助? 9571511
关于积分的说明 21818391
捐赠科研通 7778076
什么是DOI,文献DOI怎么找? 3433524
关于科研通互助平台的介绍 2557696
邀请新用户注册赠送积分活动 2479614